Tuberculosis in elephants: antibody responses to defined antigens of Mycobacterium tuberculosis, potential for early diagnosis, and monitoring of treatment.
| Abstract | Tuberculosis (TB) in elephants is a re-emerging zoonotic disease caused primarily by Mycobacterium tuberculosis. Current diagnosis relies on trunk wash culture, the only officially recognized test, which has serious limitations. Innovative and efficient diagnostic methods are urgently needed. Rapid identification of infected animals is a crucial prerequisite for more effective control of TB, as early diagnosis allows timely initiation of chemotherapy. Serology has diagnostic potential, although key antigens have not been identified and optimal immunoassay formats are not established. To characterize the humoral responses in elephant TB, we tested 143 serum samples collected from 15 elephants over time. These included 48 samples from five culture-confirmed TB cases, of which four were in Asian elephants infected with M. tuberculosis and one was in an African elephant with Mycobacterium bovis. Multiantigen print immunoassay (MAPIA) employing a panel of 12 defined antigens was used to identify serologic correlates of active disease. ESAT-6 was the immunodominant antigen recognized in elephant TB. Serum immunoglobulin G antibodies to ESAT-6 and other proteins were detected up to 3.5 years prior to culture of M. tuberculosis from trunk washes. Antibody levels to certain antigens gradually decreased in response to antitubercular therapy, suggesting the possibility of treatment monitoring. In addition to MAPIA, serum samples were evaluated with a recently developed rapid test (RT) based on lateral flow technology (ElephantTB STAT-PAK). Similarly to MAPIA, infected elephants were identified using the RT up to 4 years prior to positive culture. These findings demonstrate the potential for TB surveillance and treatment monitoring using the RT and MAPIA, respectively. |
| Authors | Konstantin P Lyashchenko, Rena Greenwald, Javan Esfandiari, John H Olsen, Ray Ball, Genevieve Dumonceaux, Freeland Dunker, Carol Buckley, Michael Richard, Suzan Murray, Janet B Payeur, Peter Andersen, John M Pollock, Susan Mikota, Michele Miller, Denise Sofranko, W Ray Waters
(Affiliation: Chembio Diagnostic Systems, Inc., 3661 Horseblock Road, Medford, New York 11763, USA. klyashchenko at chembio.com)
|
| Journal | Clinical and vaccine immunology : CVI
(Clin Vaccine Immunol)
Vol. 13
Issue 7
Pg. 722-32
(Jul 2006)
ISSN: 1556-6811 [Print] United States |
| PMID | 16829608
(Publication Type: Evaluation Studies, Journal Article, Research Support, Non-U.S. Gov't)
|
| Chemical References |
- Antibodies, Bacterial
- Antigens, Bacterial
- Bacterial Proteins
- ESAT-6 protein, Mycobacterium tuberculosis
- Immunoglobulin G
- Reagent Kits, Diagnostic
|
| Topics |
- Animals
- Antibodies, Bacterial
(blood)
- Antigens, Bacterial
(immunology)
- Bacterial Proteins
- Elephants
- Female
- Immunoassay
- Immunoglobulin G
(blood)
- Mycobacterium bovis
(immunology)
- Mycobacterium tuberculosis
(immunology)
- Reagent Kits, Diagnostic
(veterinary)
- Tuberculosis
(diagnosis, drug therapy, veterinary)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research network!
Research Interface PRO additionally includes
drill-down to evidence,
articles by author,
export to Excel,
FDA Link and
mobile subscription:
1 year subscription, $45.00 USD
    
|